浏览全部资源
扫码关注微信
1.河南中医药大学医学院,郑州 450046
2.河南中医药大学第三附属医院妇产科,郑州 450008
3.河南中医药大学临床技能实训中心,郑州 450046
Published:15 November 2022,
Received:15 April 2022,
Revised:22 September 2022,
扫 描 看 全 文
张明昊,高一盈,董文霞等.补肾强身片对多囊卵巢综合征模型大鼠的干预作用及机制研究 Δ[J].中国药房,2022,33(21):2632-2637.
ZHANG Minghao,GAO Yiying,DONG Wenxia,et al.Study on intervention effect of Bushen qiangshen tablet on polycystic ovary syndrome model rats and its mechanism[J].ZHONGGUO YAOFANG,2022,33(21):2632-2637.
张明昊,高一盈,董文霞等.补肾强身片对多囊卵巢综合征模型大鼠的干预作用及机制研究 Δ[J].中国药房,2022,33(21):2632-2637. DOI: 10.6039/j.issn.1001-0408.2022.21.13.
ZHANG Minghao,GAO Yiying,DONG Wenxia,et al.Study on intervention effect of Bushen qiangshen tablet on polycystic ovary syndrome model rats and its mechanism[J].ZHONGGUO YAOFANG,2022,33(21):2632-2637. DOI: 10.6039/j.issn.1001-0408.2022.21.13.
目的
2
研究补肾强身片对多囊卵巢综合征(PCOS)模型大鼠的干预作用及机制。
方法
2
将50只大鼠灌胃来曲唑混悬液(1 mg/kg,每天1次,连续21 d)复制PCOS模型。将造模成功的大鼠分为模型组、阳性对照组(炔雌醇环丙孕酮片0.2 mg/kg+盐酸二甲双胍片230 mg/kg)和补肾强身片低、中、高剂量组(189、378、756 mg/kg),每组10只。另取10只未造模大鼠作为正常组。各组大鼠给予相应药物干预,每天1次,连续30 d。末次给药24 h后,检测大鼠血清中雌二醇(E
2
)、睾酮(T)、促性腺激素释放激素(GnRH)、促卵泡激素(FSH)和促黄体生成素(LH)水平,计算大鼠卵巢系数,观察大鼠卵巢组织病理形态学变化,检测大鼠卵巢组织中磷脂酰肌醇3激酶(PI3K)、磷酸化蛋白激酶B(p-Akt)、磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)和葡萄糖转运蛋白4(GLUT4)的表达水平以及PI3K、Akt、mTOR、GLUT4 mRNA表达水平。
结果
2
与正常组比较,模型组大鼠卵巢系数、卵巢囊性病变评分均显著增加(
P
<0.05),血清中T、GnRH、LH水平均显著升高(
P
<0.05),血清中FSH、E
2
水平和卵巢组织中PI3K、p-Akt、p-mTOR、GLUT4蛋白表达水平及PI3K、Akt、mTOR、GLUT4 mRNA表达水平均显著降低(
P
<0.05),卵巢组织中闭锁卵泡及无卵丘的囊性卵泡数量增多,卵泡颗粒细胞层数减少。与模型组比较,补肾强身片中、高剂量组大鼠上述指标水平均显著逆转(
P
<0.05),低剂量组上述大部分指标水平显著逆转(
P
<0.05),卵巢组织病变均不同程度改善。
结论
2
补肾强身片可调节PCOS模型大鼠性激素分泌水平,改善卵巢囊性病变,其作用机制可能与上调PI3K/Akt/mTOR、PI3K/Akt/GLUT4两条信号通路有关。
OBJECTIVE
2
To study the intervention effect of Bushen qiangshen tablet on polycystic ovary syndrome (PCOS) model rats and its mechanism.
METHODS
2
Totally 50 rats were given letrozole suspension (1 mg/kg, once a day, for consecutive 21 d) instragastrically to induce PCOS model. Model rars were randomly divided into model group, positive control group (Ethinylestradiol and cyproterone acetate tables 0.2 mg/kg+Metformin hydrochloride tables 230 mg/kg), Bushen qiangshen tablet low-dose, medium-dose and high-dose groups (189, 378, 756 mg/kg), with 10 rats in each group. Another 10 healthy rats were included in normal group. Each group was given the corresponding drugs, once a day, for consecutive 30 d. Twenty-four hours after the last administration, serum levels of estrogen (E
2
), testosterone (T), gonadotropin-releasing hormone (GnRH), follicle-stimulating hormone (FSH) and luteinizing hormone (LH) were measured. The ovary index was calculated, and pathological changes of ovary were observed. The protein expressions of phosphoinositide 3-kinase (PI3K), phosphorylated protein kinase B (p-Akt), phosphorylated mammalian target of rapamycin (p-mTOR) and glucose transporter 4 (GLUT4) in ovary were detected, and mRNA expressions of PI3K, Akt, mTOR and GLUT4 in ovary were detected.
RESULTS
2
Compared with normal group, ovarian index and ovarian cystic disease score were significantly increased in model group (
P
<0.05), and serum levels of T, GnRH and LH were significantly increased (
P
<0.05); serum levels of FSH and E
2
, protein expressions of PI3K, p-Akt, p-mTOR and GLUT4, and mRNA expression of PI3K, AKT, mTOR and GLUT4 in ovarian tissue were all significantly decreased in the model group (
P
<0.05); in ovarian tissue, the number of atresia follicles and non-cumulus cystic follicles increased, and the number of granulosa cell layers decreased. Compared with model group, above indexes of Bushen qiangshen tablet medium-dose and high-dose groups were reversed significantly (
P
<0.05), and most above indexes of low-dose group were reversed significantly (
P
<0.05), the pathological changes of ovarian tissue were improved to varying degrees.
CONCLUSIONS
2
Bushen qiangshen tablet can regulate the secretion of sex hormones in PCOS model rats and improve ovarian cystic lesions. Its mechanism may be related to the upregulation of PI3K/Akt/mTOR and PI3K/Akt/GLUT4 signaling pathways.
补肾强身片多囊卵巢综合征PI3K/Akt/mTOR信号通路PI3K/Akt/GLUT4信号通路
polycystic ovary syndromePI3K/Akt/mTOR signaling pathwayPI3K/Akt/GLUT4 signaling pathway
高梦雅,洪艳丽,崔媚婷,等.补肾化痰方治疗多囊卵巢综合征的作用机制:基于网络药理学和分子对接方法[J].南方医科大学学报,2022,42(1):1-12.
宋甜,付琳琳,王秋敏,等.脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J].山东大学学报(医学版),2022,60(2):22-26.
HOEGER K M,DOKRAS A,PILTONEN T. Update on PCOS:consequences,challenges,and guiding treatment[J]. J Clin Endocrinol Metab,2021,106(3):e1071-e1083.
沈文娟,金宝,李浦媛,等.中医药治疗多囊卵巢综合征高雄激素血症研究进展[J].中国中医基础医学杂志,2021,27(4):694-697.
吴登辉,韩延华,杨丽珍,等.从中医阴阳理论探讨多囊卵巢综合征与细胞自噬的相关性[J].中华中医药杂志,2021,36(8):4526-4528.
钱丽旗,李素那,于洋,等.夏桂成治疗多囊卵巢综合征致不孕症经验[J].中医杂志,2020,61(20):1775-1778.
林秀莲,宋粉云,李华,等.UPLC同时测定补肾强身片中6种化学成分的含量[J].中国实验方剂学杂志,2017,23(20):56-60.
李康梅,戴明明,黎明星,等.基于网络药理学研究淫羊藿治疗多囊卵巢综合征的作用机制[J].中医药导报,2020,26(11):101-105.
余璟玮,钟晓莹,曾蕾,等.桂枝茯苓丸对痰湿型多囊卵巢综合征模型大鼠的改善作用及机制研究[J].中国药房,2021,32(1):39-45.
张慧英,张艳芳,韩玉崑,等.多囊卵巢综合征患者子宫内膜组织中胰岛素PI3K/Akt信号通路的活化及其意义[J].中华妇产科杂志,2012,47(1):19-23.
刘敏,朱鸿秋,李印,等.桂枝茯苓丸调节PI3K/Akt/mTOR通路对PCOS-IR大鼠排卵障碍的影响[J].中国实验方剂学杂志,2021,27(6):7-14.
苗明三,彭孟凡,闫晓丽.菟丝子总黄酮对多囊卵巢综合征大鼠模型的影响[J].中国实验方剂学杂志,2019,25(5):143-150.
苗晋鑫,李秀敏,苗明三.多囊卵巢综合征动物模型数据挖掘及分析[J].中国比较医学杂志,2020,30(2):135-140,146.
沈文娟,李欣,金宝,等.多囊卵巢综合征高雄激素血症中西医研究进展[J].辽宁中医杂志,2022,49(2):209-213.
方慧祥,杨坤芬,冯玉茹.RP-HPLC法测定补肾强身片中金丝桃苷的含量[J].中国药房,2015,26(3):413-415.
张彩宇,陶爱群,莫有珍.二甲双胍与炔雌醇环丙孕酮片联用对多囊卵巢综合征患者相关激素分泌水平的影响[J].中国现代医学杂志,2016,26(9):85-88.
SHIN J J,PARK K E,CHOI Y M,et al. Early gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome:a preliminary randomized trial[J]. Clin Exp Reprod Med,2018,45(3):135-142.
LUQUE-RAMÍREZ M,ESCOBAR-MORREALE H F. Targets to treat androgen excess in polycystic ovary syndrome[J]. Expert Opin Ther Targets,2015,19(11):1545-1560.
尹利军,王晓慧.雄激素及其受体在肥胖、肥胖相关疾病及糖脂代谢紊乱中的作用[J].生理学报,2018,70(3):319-328.
ZHANG C Y,MA J,WANG W S,et al. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome[J]. Hum Reprod,2018,33(11):2096-2106.
GONG Y,LUO S,FAN P,et al. Growth hormone activates PI3K/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome[J]. Reprod Biol Endocrinol,2020,18(1):121.
CAI Z W,HE S J,LI T,et al. Plumbagin inhibits proliferation and promotes apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inactivating PI3K/Akt/mTOR pathway[J]. Anim Cells Syst (Seoul),2020,24(4):197-204.
KUANG H Y,DUAN Y W,LI D,et al. The role of serum inflammatory cytokines and berberine in the insulin sig- naling pathway among women with polycystic ovary syndrome[J]. PLoS One,2020,15(8):e0235404.
XIANG S,XIA M F,SONG J Y,et al. Effect of electro-acupuncture on expression of IRS-1/PI3K/GLUT4 pathway in ovarian granulosa cells of infertile patients with polycystic ovary syndrome-insulin resistance of phlegm-dampness syndrome[J]. Chin J Integr Med,2021,27(5):330-335.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution